April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

April 25, 2025

Cinnamon Oil May Trigger Drug Interactions

Cinnamaldehyde may modestly activate drug-metabolizing receptors, raising potential herb–drug interaction concerns.

Conexiant

April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant

April 24, 2025

Vitamin D Multifaceted CRC Immunomodulator Revealed

"Vitamin D enhances immune organ functions such as the spleen and lymph nodes, and boosts T-cell activity, which is essential in defending the body against tumors."

Conexiant

April 24, 2025

Karen E. Knudsen, MBA, PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy (PICI) announced the appointment of Karen E. Knudsen, MBA, PhD, as its new Chief Executive Officer (CEO). A visionary leader in oncology, health-care deli...

The ASCO Post

April 24, 2025

WHI Funding Cuts Threaten Research Continuity

HHS will terminate WHI Regional Center funding in September 2025.

Conexiant

April 24, 2025

Old Drug, New Trick for Joint Pain

Can a common diabetes drug double as a treatment for knee osteoarthritis?

Conexiant

April 23, 2025

FDA Targets Petroleum-Based Dyes in Food Supply

The FDA and HHS announced plans to eliminate petroleum-based synthetic food dyes, citing potential health risks and aligning with global safety standards.

Conexiant